Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: The role of poly(ADP-ribose) polymerase

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 8, 2004, Pages 1453-1459

  Piconi, L ^d   Quagliaro, L ^d   Da Ros, R ^a   Assaloni, R ^a   Giugliano, D ^b   Esposito, K ^b   Szabo C ^c   Ceriello, Antonio ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c INOTEK CORPORATION   (United States)

^d Morpurgo Hofman Research Laboratory on Aging   (Italy)

Author keywords

E selectin; ICAM 1; IL 6; Intermittent glucose; Poly (ADP ribose) polymerase; VCAM 1

Indexed keywords

3 NITROTYROSINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; VASCULAR CELL ADHESION MOLECULE 1;

AMINO ACID SYNTHESIS; ARTICLE; CARDIOVASCULAR DISEASE; CELL CULTURE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INFLAMMATION; NITROSATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

BLOTTING, NORTHERN; CELLS, CULTURED; E-SELECTIN; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; NITROGEN; OSCILLOMETRY; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASES; RNA, MESSENGER; TIME FACTORS; TYROSINE; UMBILICAL VEINS; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 13244262637     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00835.x     Document Type: Article

References (34)

1. Kannel WB, McGee DL. Diabetes and cardiovascular diseases. The Framingham Study. JAMA 1979; 241: 2035-8.
2. Ruosladti E. Integrins. J Clin Invest 1991; 187: 1-5.
3. Lopes-Virella MF, Virella G. Immune mechanism of atherosclerosis in diabetes mellitus. Diabetes 1992; 41 (Suppl. 2): 86-91.
4. Kado S, Wakatsuki T, Yamamoto M, Nagata N. Expression of intracellular adhesion molecule-1 induced by high glucose concentrations in human aortic endothelial cells. Life Sci 2001; 68: 727-37.
5. Morigi M, Angioletti S, Imberti B, Donatelli R, Micheletti G, Figliuzzi M, Remuzzi A, Zoja C, Remuzzi G. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-κB-dependent fashion. J Clin Invest 1998; 101: 1905-15.
6. Cominacini L, Fratta Pasini A, Garbin U, Campagnola, M, Davoli A, Rigoni A, Zenti MG, Pastorino AM, Lo Cascio V. E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress. Diabetologia 1997; 40: 584-9.
7. Ceriello A, Falletti E, Motz E, Taboga C, Tonutti L, Ezsol Z, Gonano F, Bartoli E. Hyperglycemia-induced ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. Horm Metab Res 1998; 30: 146-9.
8. Morohoshi M, Fujisawa K, Uchimura I, Numano F. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 1996; 45: 954-9.
9. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002; 106: 2067-72.
10. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20.
11. Garcia Soriano F, Virag L, Jagtap P, Szabo E, Mabley JG, Liaudet L, Marton A, Hoyt DG, Murthy KG, Salzman AL, Southan GJ, Szabo C. Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation. Nat Med 2001; 7: 108-13.
12. Zingarelli B, Salzman AL, Szabo C. Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ Res 1998; 13: 85-94.
13. Soriano FG, Virag L, Szabo C. Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly (ADP-ribose) polymerase activation. J Mol Med 2001; 79: 437-48.
14. Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, Taboga C. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 2001; 44: 834-8.
15. Ceriello A, Quagliaro L, D'Amico M, Di Filippo C, Martella R, Nappo F, Berrino L, Rossi F, Giugliano D. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 2002; 51: 1076-82.
16. Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol 2001; 281: E924-E930.
17. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD (P) H-oxidase activation. Diabetes 2003; 52: 2795-804.
18. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 1998; 356: 1-11.
19. Abdelkarim GE, Gertz K, Harms C, Katchanov J, Dirnagl U, Szabo C, Endres M. Protective effects of PJ34, a novel, potent inhibitor of poly (ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Int J Mol Med 2001; 7: 255-60.
20. Jaffe EA, Nachman RL, Becker CG, Minich CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973; 52: 2745-52.
21. Bluher M, Unger R, Rassoul F, Richter V, Paschke R. Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes. Diabetologia 2002; 45: 210-6.
22. Koga M, Otsuki M, Kubo M, Hashimoto J, Kasayama S. Relationship between circulating vascular cell adhesion molecule-1 and microvascular complications in type 2 diabetes mellitus. Diabet Med 1998; 15: 661-7.
23. Fasching P, Veitl M, Rohac M, Streli C, Schneider B, Waldhausl W, Wagner OF. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996; 81: 4313-7.
24. Muller S, Martin S, Koenig W, Hanifi-Moghaddam P, Rathmann W, Haastert B, Giani G, Illig T, Thorand B, Kolb H. Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia 2002; 45: 805-12.
25. Bonora E, Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia 2001; 44: 2107-14.
26. Ceriello A. The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications. Diabet Med 1998; 15: 188- 93.
27. Ceriello A. Acute hyperglycaemia and oxidative stress generation. Diabet Med 1997; 14: S45-S49.
28. Marfella R, Esposito K, Giunta R, Coppola G, DeAngelis L, Farzati B, Prolisso G, Giugliano D. Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation 2000; 101: 2247-51.
29. Virag L, Szabo C. The therapeutic potential of poly (ADP-ribose) polymerase inhibitors. Pharmacol Rev 2002; 54: 375-429.
30. Brennan ML, Wu W, Fu X, Shen Z, Song W, Frost H, Vadseth C, Narine L, Lenkiewicz E, Borchers MT, Lusis AJ, Lee JJ, Lee NA, Abu-Soud HM, Ischiropoulos H, Hazen SL. A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem 2002; 17: 17415-27.
31. Szabo C, Virag L, Cuzzocrea S, Scott GS, Hake P, O'Connor MP, Zingarelli B, Salzman A, Kun E. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly (ADP-ribose) synthase. Proc Natl Acad Sci USA 1998; 95: 3867-72.
32. Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S, de la Rubia G, Stoclet JC, de Murcia G. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 1999; 18: 4446-54.
33. Virag L, Salzman AL, Szabo C. Poly (ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. J Immunol 1998; 161: 3753-9.
34. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003; 290: 486-94.